S

Director Director DIN 10278181
DIN 10278181 First appointment Sep 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2023
Shareholding value •••• Premium profile

About Sudhakar

Data last updated:

Sudhakar was a Director at Ultra Chiron Pharmaceuticals Pvt Ltd (2023–2025) and Director at Quixotic Pharma Private Limited (2023–2025). The companies operate in Pharma.

DIN 10278181
Primary Designation Director
Industry Pharma
First Appointment 11 Sep 2023

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ultra Chiron Pharmaceuticals Pvt Ltd U24231CH1993PTC013535
Director11 Sep 20231993₹6.09 Cr (FY 2025)Active
Quixotic Pharma Private Limited U24232PB2002PTC025609
Director11 Sep 20232002₹27.58 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ultra Chiron Pharmaceuticals Pvt Ltd
Quixotic Pharma Private Limited
Premium access

Shareholding and investment profile for Sudhakar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sudhakar

Sudhakar was first appointed on 11 Sep 2023 as Director at Ultra Chiron Pharmaceuticals Pvt Ltd.

Sudhakar held 2 earlier board appointments: Ultra Chiron Pharmaceuticals Pvt Ltd (Director, 11 Sep 2023 to 06 Mar 2025); Quixotic Pharma Private Limited (Director, 11 Sep 2023 to 06 Mar 2025).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available